In lung tissue, males presented increased expression of IL ... at a frequency of 70 breaths/min and a tidal volume of 10 mL/kg. For BD induction, a Fogarty® 4F catheter was inserted intracranially and ...

Maria Fogarty’s backyard used to be a place to play with her children, but over the last few months Fogarty has slowly transformed it into a miniature farm. When the pandemic hit, Fogarty was ...

This study presents compelling evidence that the denitrosylase SCoR2 regulates cardioprotective metabolic reprogramming in the heart following ischemia/reperfusion injury. The findings are supported ...

Nosocomial infections related to the development of catheter-related infections are a leading cause of morbidity and mortality among critically ill hospitalized patients. Despite important ...

A single G5 pneumonitis event was recorded in a 70-year old man with a history of prior carboplatin/etoposide chemotherapy, chronic obstructive pulmonary disease, and radiation to the lung and pleural ...

T-DOC ® Air-Charged™ disposable catheters use tiny pressure-sensing air balloons to assess internal pressures. Barely larger than the diameter of the catheter itself, these balloons offer ...

Apr. 22, 2025 — Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...

Lung cancer starts in your lungs and can spread to other parts of your body. There are more than 20 kinds of lung cancer. Some other conditions can have similar warning signs to lung cancer. It ...

French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC).

Bayer has advanced its small-molecule drug BAY 2927088 into phase 3 for non-small cell lung cancer (NSCLC) with HER2 activating mutations, one of the drugs central to the company’s plan to ...

Data from the TROPION-Lung02 reported at the World Congress on Lung Cancer (WCLC) showed an overall response rate of 37% when DS-1062 (datopotamab deruxtecan) was combined with Merck & Co's PD-1 ...

The coveted designation for GSK5764227 (GSK'227, previously known as HS-20093) is for the use of the ADC to treat relapsed or refractory extensive-stage small-cell lung cancer (SCLC) and comes ...